会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 61. 发明授权
    • Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
    • 安全霉素类抗坏血病素系列化合物,用途及其合成
    • US06936714B2
    • 2005-08-30
    • US10728580
    • 2003-12-05
    • Samuel J. DanishefskyBishan Zhou
    • Samuel J. DanishefskyBishan Zhou
    • A61K31/4995A61P35/00C07C271/22C07D217/24C07D471/18C07D491/04C07D491/056C07D491/22C07D471/14
    • C07D491/04C07D217/24
    • Compounds of the saframycin-ecteinascidin series with cytotoxic properties having the following general formula, their uses and synthesis, are disclosed: wherein R1 and R4 is H, a C1 to C4 alkyl group, or an acyl group; wherein R2 is an ether, ester, amide, or a phthalimide group; wherein R3 is ═O, OH, an ether group, an acyl group such as OC(O)Me, OC(O)Bn and OC(O)Et, or a sulfide group; wherein R5 is H, halogen, OH, an ether group, an acyl group, or an amide group; wherein R6 is ═O, OH, OCH3, CN, or an acyloxy group; wherein R7, is ═O, OH, halogen, an ether group, or an acyl group; wherein R8 and R9 are independently H, CH3, OCH3, OC2H5, CF3, halogen such as Br and F, or R8 and R9 are joined together as a methylenedioxy group, or other five or six membered ring; wherein R10 and R11 are independently CH3, OCH3, OC2H5, SCH3, or SC2H5; wherein R12 is H, a C1 to C4 alkyl group, or an acyl group; and wherein the chiral center marked * has the R or the S configuration.
    • 公开了具有以下通式及其用途和合成的具有细胞毒性的安全霉素 - 白in素类化合物的化合物:其中R 1和R 4均为H,C < 或C 1至C 4烷基,或酰基; 其中R 2是醚,酯,酰胺或邻苯二甲酰亚胺基团; 其中R 3为-O,OH,醚基,酰基如OC(O)Me,OC(O)Bn和OC(O)Et)或硫醚基; 其中R 5是H,卤素,OH,醚基,酰基或酰胺基; 其中R 6为-O,OH,OCH 3,CN或酰氧基; 其中R 7为-O,OH,卤素,醚基或酰基; 其中R 8和R 9独立地为H,CH 3,OCH 3,OC 2, CH 3,CF 3,卤素如Br和F,或R 8和R 9, 作为亚甲二氧基或其它五元或六元环连接在一起; 其中R 10和R 11独立地是CH 3,OCH 3,OC 2, 5 H 3,SCH 3,或SC 2 H 5; 其中R 12是H,C 1至C 4烷基或酰基; 并且其中标记为*的手性中心具有R或S构型。
    • 67. 发明授权
    • Camptothecin analogues and methods of preparation thereof
    • 喜树碱类似物及其制备方法
    • US5525731A
    • 1996-06-11
    • US328415
    • 1994-10-25
    • Samuel J. DanishefskyLawrence B. Snyder
    • Samuel J. DanishefskyLawrence B. Snyder
    • C07D491/14C07D491/147C07D491/22C07H17/00A61K31/435
    • C07D491/14C07H17/00
    • Substituted analogues of camptothecin possessing cytotoxic activity towards cancer cells, of the general structure: ##STR1## wherein E is H, CO.sub.2 R, CONH.sub.2, CONHR, CONR.sub.2, or CN; R.sup.0 and R.sup.1 are independently the same or different and are H, or a linear or branched alkyl, linear or branched alkylaryl, hydroxyalkyl or aryl group; R.sup.2, R.sup.3 and R.sup.4 are independently the same or different and are H, or a linear or branched alkyl, linear or branched alkylaryl, hydroxyalkyl or aryl group; R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 are independently the same or different and are H, or a linear or branched alkyl, linear or branched alkylaryl or aryl group, or an alkoxy, aryloxy, hydroxyalkyl, C-glycal, nitro, cyano or aminoalkoxy group, or CO.sub.2 R, Cl, F, Br, I, SR.sup.10, NR.sup.11 R.sup.12 or OR.sup.13 ; R is H, an alkyl, aryl, alkylaryl or hydroxyalkyl group; R.sup.10, R.sup.11 and R.sup.12 are independently the same or different and are H, an alkyl, aryl, alkylaryl or acyl group; R.sup.13 is glycosyl; and n is 0 or 1. Also provided are compositions comprising the analogues and methods of treating tumors as well as methods for preparing the analogues.
    • 具有一般结构的具有对癌细胞的细胞毒性活性的喜树碱的取代类似物:其中E是H,CO 2 R,CONH 2,CONHR,CONR 2或CN; R 0和R 1独立地相同或不同,为H,或直链或支链烷基,直链或支链烷基芳基,羟烷基或芳基; R2,R3和R4独立地相同或不同,为H,或直链或支链烷基,直链或支链烷基芳基,羟基烷基或芳基; R 5,R 6,R 7,R 8和R 9独立地相同或不同,为H,或直链或支链烷基,直链或支链烷基芳基或芳基,或烷氧基,芳氧基,羟基烷基,C-缩醛,硝基,氰基或 氨基烷氧基或CO2R,Cl,F,Br,I,SR10,NR11R12或OR13; R是H,烷基,芳基,烷基芳基或羟烷基; R 10,R 11和R 12独立地相同或不同,为H,烷基,芳基,烷基芳基或酰基; R13是糖基; 并且n为0或1.还提供了包含治疗肿瘤的类似物和方法的组合物以及制备类似物的方法。